Schizophrenia after adequately treated with Invega Sustenna (1-month paliperidone palmitate ext-rel inj susp) for at least 4 months, or with Invega Trinza (3-month paliperidone palmitate ext-rel ...

Schizophrenia after adequately treated with Invega Sustenna (1-month paliperidone palmitate ext-rel inj susp) for at least 4 months. Establish tolerability with Invega Sustenna prior to initiating.

This leaflet answers some of the common questions about Invega Trinza. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.

The FDA approval is based on data showing it is as effective as Invega Trinza formulation, keeping 92.5% of patients relapse-free at 12 months compared to 95% of the comparator group.